Testosterone impaired docetaxel antitumour activity through two different modes of action: interference with docetaxel tumour accumulation, thereby reducing tubulin stabilisation and AR-pathway activation protecting cells from docetaxel-induced cell death (Fig. 1b). Here, AR is linked to neoplasm.